JDRF Blog

Dr. Esteban N. Gurzov, a talented young scientist from Brussels, Belgium, was recently named the first recipient of JDRF’s Dr. Robert Goldstein Award.

From Walk participant to trial participant to T1D advocate, here is Ash Hunkin’s story.

Dr. Rémi Rabasa-Lhoret, a JDRF-funded endocrinologist at the Institut de recherches cliniques de Montréal best known for his work on the artificial pancreas, is overseeing the initiative to collect data for the Quebec-wide registry of people with T1D in order to track the incidence of hypoglycemic episodes and allow patients to better manage their disease.

Does Vitamin D play a role in developing type 1 diabetes (T1D)?

Administering insulin on a daily basis can be a tedious task, particularly among individuals newly diagnosed with type 1 diabetes (T1D). To mitigate this, researchers are currently experimenting with islet (insulin-producing cells) transplantation as a promising therapy that eliminates the need for insulin injections.

Since 2016, JDRF and Sernova Corp., a clinical-stage regenerative medicine company, have been collaborating on innovative technology to treat hypoglycaemia (low sugar) unawareness in patients with severe T1D.

JDRF is excited to be launching our new Access for All campaign this week to urge provincial and territorial governments, insurers and employers to help make life-changing technologies affordable and accessible for Canadians with type 1 diabetes.

Currently, JDRF-funded researcher, Dr. Jan Dutz, and his team at the University of British Columbia are investigating whether the administration of an antibody called ustekinumab among adults and children newly diagnosed with T1D can protect insulin-producing beta cells.

Currently, JDRF-funded researcher, Dr. Jan Dutz, and his team at the University of British Columbia are investigating whether the administration of an antibody called ustekinumab among adults and children newly diagnosed with T1D can protect insulin-producing beta cells.

New technologies for people with type 1 diabetes (T1D) can significantly improve quality of life, but only a limited number of individuals have access to them.

As the incidence of type 1 diabetes (T1D) continues to grow, Canadians have long speculated whether environmental factors – namely pollution – could be responsible for triggering an autoimmune attack.

While the winter season can be a fun time filled with skiing, sledding and mugs of steaming cocoa, it can also be marked by not-so-fun events like the flu, sick days and visits to the clinic.